	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S14-PMC2582131	PMC2582131	11/2008	S14-PMC2582131	['HOWEVER, the ubiquitous distribution of Intracellular Vitamin D Receptor across diverse Tissues[1]and the EMERGING epidemiological EVIDENCE DOCUMENTING INCREASED RISKS of hypertension[2],[3], Cardiovascular disease[4]–[7], and selected cancers[1],[8]ASSOCIATED with Vitamin D deficiency underscore the pleiotropic actions of Vitamin D. evidence is also accumulating for a ROLE of Vitamin D in maintaining normal Glucose Homeostasis.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 372)]	6	[('GO_0005622', 'intracellular anatomical structure', 40, 'intracellular'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 54, 'vitamin D receptor'), ('UBERON_0000479', 'tissue', 88, 'tissues'), ('UBERON_0004535', 'cardiovascular system', 192, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_17234', 'glucose', 412, 'glucose'), ('GO_0042593', 'glucose homeostasis', 412, 'glucose homeostasis')]
S86-PMC2582131	PMC2582131	11/2008	S86-PMC2582131	['it has become increasingly CLEAR that Vitamin D has physiological functions beyond bone health[6]; Vitamin D receptors were Expressed in a large number of other Tissues including those INVOLVED in the Regulation Of Glucose Metabolism, such as Muscle and Pancreatic Β Cells[1].']	[('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 185)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0010467', 'gene expression', 124, 'expressed'), ('UBERON_0000479', 'tissue', 161, 'tissues'), ('GO_0010906', 'regulation of glucose metabolic process', 201, 'regulation of glucose metabolism'), ('CHEBI_17234', 'glucose', 215, 'glucose'), ('CL_0000187', 'muscle cell', 243, 'muscle ...'), ('CL_0000173', 'pancreatic D cell', 254, 'pancreatic β cells'), ('UBERON_0001264', 'pancreas', 254, 'pancreatic')]
S157-PMC2996405	PMC2996405	11/2010	S157-PMC2996405	['Vitamin D receptors were FOUND in most Tissues OTHER than those classically INVOLVED in the Vitamin D action (bone, Gut, Kidney, etc.).']	[('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000479', 'tissue', 39, 'tissues'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 116, 'gut'), ('UBERON_0002113', 'kidney', 121, 'kidney')]
S15-PMC3032617	PMC3032617	5/2010	S15-PMC3032617	['kallner et al., have DEMONSTRATED that at Tissue saturation, whole body Vitamin C content is approximately 20mg/kg, or 1500mg, and that during depletion its loss is at a rate of 3% of whole-body content per day [4].']	[('INCOMPLETE_EVIDENCE', 21)]	1	[('UBERON_0000479', 'tissue', 42, 'tissue'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin C')]
S8-PMC3277098	PMC3277098	12/2011	S8-PMC3277098	['we now KNOW that all Tissues in the body posses receptors for the active form of Vitamin D, 1,25-Dihydroxyvitamin D (1α,25(Oh)2D3) and it HAS RECENTLY BEEN DISCOVERED that there are Extrarenal Tissues capable of converting 25(Oh)D to the active Metabolite, including certain Immune Cells [1,2].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 138), ('INCOMPLETE_EVIDENCE', 156)]	3	[('UBERON_0000479', 'tissue', 21, 'tissues'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_67472', '15-epi-lupulin B', 92, '1,25-dihydroxyvitamin D'), ('CHEBI_34898', 'OM-174', 123, 'OH)2D3'), ('UBERON_0005292', 'extraembryonic tissue', 182, 'extrarenal tissues'), ('CHEBI_71657', 'versiconol acetate', 223, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 245, 'metabolite'), ('CL_0000738', 'leukocyte', 275, 'immune cells'), ('UBERON_0002405', 'immune system', 275, 'immune')]
S50-PMC3277098	PMC3277098	12/2011	S50-PMC3277098	['to date, the MAJORITY of research HAS BEEN conducted using cells sourced from peripheral Blood; HOWEVER SOME authors have PROPOSED that Gut-associated lymphoid Tissue MAY be of RELEVANCE, particularly in regard to oral Vitamin D Intake and Food Allergen sensitization [33].']	[('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 122), ('INCOMPLETE_EVIDENCE', 167), ('IMPORTANT_CONSIDERATION', 177)]	7	[('UBERON_0000178', 'blood', 89, 'blood'), ('UBERON_0001555', 'digestive tract', 136, 'gut'), ('UBERON_0000479', 'tissue', 160, 'tissue'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('GO_0007631', 'feeding behavior', 229, 'intake'), ('CHEBI_33290', 'food', 240, 'food'), ('CHEBI_50904', 'allergen', 245, 'allergen')]
S63-PMC3277098	PMC3277098	12/2011	S63-PMC3277098	['[4] FOUND that Vitamin D deficiency in Mice is significantly ASSOCIATED with decreased Lung volume, Tissue volume and increased Airway resistance.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 61)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 39, 'mice'), ('UBERON_0002048', 'lung', 87, 'lung'), ('UBERON_0000479', 'tissue', 100, 'tissue'), ('UBERON_0001005', 'respiratory airway', 128, 'airway')]
S64-PMC3277098	PMC3277098	12/2011	S64-PMC3277098	['they PROPOSED that, as reduced Lung volume is a RISK FACTOR for Lung function and Respiratory illness in Humans, Vitamin D deficiency COULD increase the risk of these conditions through EFFECTS on Lung Tissue growth.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 134), ('SUPERFICIAL_RELATIONSHIP', 186)]	4	[('UBERON_0002048', 'lung', 31, 'lung'), ('UBERON_0002048', 'lung', 64, 'lung'), ('UBERON_0001004', 'respiratory system', 82, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 105, 'humans'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0002048', 'lung', 197, 'lung'), ('UBERON_0000479', 'tissue', 202, 'tissue')]
S101-PMC3277098	PMC3277098	12/2011	S101-PMC3277098	['functional consequences of vdr polymorphisms MAY, THEREFORE, vary with the availability of Vitamin D to Tissues and become apparent, OR exaggerated, in an environment of Vitamin d deficiency, such as observed in the case of several infectious diseases [45,46].']	[('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('UBERON_0000479', 'tissue', 104, 'tissues'), ('CHEBI_33229', 'vitamin (role)', 170, 'vitamin')]
S110-PMC3347028	PMC3347028	3/2012	S110-PMC3347028	['in addition, BASED on rickets and osteoporosis data, it APPEARS that bone health, which is LINKED with Renal production of 1,25(Oh)2D and Calcium Metabolism is maintained at significantly lower levels of circulating Vitamin D concentrations COMPARED to OTHER health factors such as Immune function, which is dependent on delivery of 25(Oh)D to cells of the target Tissue.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ANOMALY_CURIOUS_FINDING', 56), ('SUPERFICIAL_RELATIONSHIP', 91), ('ANOMALY_CURIOUS_FINDING', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 253)]	5	"[('UBERON_0002113', 'kidney', 103, 'renal'), ('CHEBI_37958', 'dye', 123, '1,'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 125, '25(OH)2D'), ('CHEBI_22313', 'alkaline earth metal atom', 138, 'calcium'), ('GO_0018884', 'carbazole metabolic process', 138, 'calcium metabolism'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('UBERON_0002405', 'immune system', 282, 'immune'), ('CHEBI_71657', 'versiconol acetate', 333, '25(OH)D'), ('UBERON_0000479', 'tissue', 364, 'tissue')]"
S15-PMC3427250	PMC3427250	8/2012	S15-PMC3427250	['the ubiquitous presence of Vitamin D receptors in most Tissues, including the Placenta, SUGGESTS that Vitamin D MAY have OTHER ROLES as well.']	[('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0000479', 'tissue', 55, 'tissues'), ('UBERON_0001987', 'placenta', 78, 'placenta'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
S102-PMC3427250	PMC3427250	8/2012	S102-PMC3427250	['the ASSOCIATION of Vitamin D status with bmi HAS BEEN ATTRIBUTED to an excessive Storage Of Vitamin D in fat Tissue decreasing thereby Serum concentrations[47].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0030730', 'sequestering of triglyceride', 81, 'storage of vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('UBERON_0000479', 'tissue', 109, 'tissue'), ('UBERON_0001977', 'blood serum', 135, 'serum')]
S159-PMC3458940	PMC3458940	9/2012	S159-PMC3458940	['moreover, post-Natal Vitamin A deficiency HAS BEEN ASSOCIATED with Renal anomalies, including increased incidence of pyelonephritis, Kidney inflammation and fibrosis, polyuria and Dysregulated Urinary Ion/solute content, urolithiasis, and delayed Tissue Repair[7],[41],[42],[43],[44].']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('GO_0007567', 'parturition', 15, 'natal'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('UBERON_0002113', 'kidney', 67, 'renal'), ('UBERON_0002113', 'kidney', 133, 'kidney'), ('GO_0060203', 'clathrin-sculpted glutamate transport vesicle membrane', 180, 'dysregulated'), ('UBERON_0001088', 'urine', 193, 'urinary'), ('CHEBI_24870', 'ion', 201, 'ion'), ('UBERON_0000479', 'tissue', 247, 'tissue'), ('GO_0006281', 'DNA repair', 254, 'repair')]
S136-PMC3515553	PMC3515553	12/2012	S136-PMC3515553	['rs1801198 is a non-synonymous polymorphism (p259r) that HAS BEEN REPORTED to decrease transcription and the cellular and Plasma concentration of holo-transcobalamin, which is the biologically active fraction of Vitamin B-12 delivered to Tissues[13],[29].']	[('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 65)]	2	[('UBERON_0001969', 'blood plasma', 121, 'plasma'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 211, 'vitamin B-12'), ('UBERON_0000479', 'tissue', 237, 'tissues')]
S13-PMC3641012	PMC3641012	4/2013	S13-PMC3641012	['HOWEVER, the EFFECTS of Vitamin D on maternal, Placental or Fetal Tissues are UNCERTAIN [2], and the extent to which health outcomes are responsive to changes in maternal-fetal Vitamin D status REMAINS UNKNOWN [2,6,7].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 78), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001987', 'placenta', 47, 'placental'), ('UBERON_0000922', 'embryo', 60, 'fetal'), ('UBERON_0000479', 'tissue', 66, 'tissues'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
S24-PMC3651971	PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]
S15-PMC3672018	PMC3672018	5/2013	S15-PMC3672018	['widely distributed in body Tissues, a vdr, once bound to a Vitamin D ligand, travels to the Nucleus where it binds to sites within the Human Genome and CONSEQUENTLY INFLUENCES the activity, or Expression, of individual Genes.']	[('PROBABLE_UNDERSTANDING', 152), ('SUPERFICIAL_RELATIONSHIP', 165)]	2	[('UBERON_0000479', 'tissue', 27, 'tissues'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0005634', 'nucleus', 92, 'nucleus'), ('NCBITaxon_9606', 'Homo sapiens', 135, 'human'), ('SO_0001026', 'genome', 141, 'genome'), ('GO_0010467', 'gene expression', 193, 'expression'), ('SO_0000704', 'gene', 219, 'genes')]
S23-PMC3672018	PMC3672018	5/2013	S23-PMC3672018	['Animal Tissues consumed as Food provide additional sources of this hormone-like vitamin, WHILE Plant foods MAY provide the less potent form of Vitamin D: Ergocalciferol (Vitamin D2) [7].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('INCOMPLETE_EVIDENCE', 107)]	2	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('UBERON_0000479', 'tissue', 7, 'tissues'), ('CHEBI_33290', 'food', 27, 'food'), ('NCBITaxon_33208', 'Metazoa', 95, 'plant'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_4910', 'etomidate', 154, 'ergocalciferol'), ('CHEBI_28934', 'vitamin D2', 170, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 170, 'vitamin D2')]
S34-PMC3672018	PMC3672018	5/2013	S34-PMC3672018	['adverse health EFFECTS of low Vitamin D MAY THEREFORE be MOST evident in Organs or Tissues whose development occurs in these trimesters, e.g.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 57)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000062', 'organ', 73, 'organs'), ('UBERON_0000479', 'tissue', 83, 'tissues')]
S6-PMC3702245	PMC3702245	6/2013	S6-PMC3702245	['in addition, it is now known to be INVOLVED in Immunomodulation, Cell Proliferation, and Cell Differentiation, and in other physiologic functions in diverse Tissues and Organs, including the Brain, Pancreas, and Heart.6despite the REPORTED high prevalence of Vitamin D deficiency and its POSSIBLE consequences, the criteria for defining an optimal level in the body, and HENCE the amount of Vitamin D intake REQUIRED to maintain adequate levels, is CONTROVERSIAL.3,7,8this overview addresses the CURRENT INFORMATION about Vitamin D function, the GLOBAL BURDEN and POTENTIAL consequences of low Vitamin D status in Pregnancy, and current STRATEGIES to optimize Vitamin D status in Pregnant mothers and their offspring.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 288), ('PROBABLE_UNDERSTANDING', 371), ('IMPORTANT_CONSIDERATION', 408), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 449), ('INCOMPLETE_EVIDENCE', 496), ('IMPORTANT_CONSIDERATION', 546), ('INCOMPLETE_EVIDENCE', 564), ('FUTURE_WORK', 637)]	10	[('GO_0050900', 'leukocyte migration', 47, 'immunomodulation'), ('GO_0008283', 'cell proliferation', 65, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 89, 'cell differentiation'), ('UBERON_0000479', 'tissue', 157, 'tissues'), ('UBERON_0000062', 'organ', 169, 'organs'), ('UBERON_0000955', 'brain', 191, 'brain'), ('UBERON_0001264', 'pancreas', 198, 'pancreas'), ('UBERON_0000948', 'heart', 212, 'heart'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 594, 'vitamin D'), ('GO_0007565', 'female pregnancy', 614, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('GO_0007565', 'female pregnancy', 680, 'pregnant')]
S10-PMC3702245	PMC3702245	6/2013	S10-PMC3702245	['a second hydroxylation takes place in the Kidney, which converts 25(Oh)D to the most biologically active Metabolite, 1,25-Dihydroxyvitamin D, the major classical physiologic function of which is to increase calcium and Phosphorus absorption from the Gut in order to maintain Calcium Homeostasis and promote mineralization of Osteoid bone.9\nalthough the Renal 1-alpha hydroxylase (Cytochrome P450 [Cyp]27B1) enzyme is a MAJOR DETERMINANT of Synthesis of 1,25-Dihydroxyvitamin D, IT IS KNOWN that Cyp27B1 is Expressed in Nonrenal Tissues to produce 1,25 Dihydroxyvitamin D.6,19in addition, Vitamin D receptors are also Expressed in a variety of Organs, Tissues, and cells (seefigure 1).20the 1,25-Dihydroxyvitamin D locally produced in Extrarenal Tissues, such as immune cells, Pancreatic Beta Cells, the Intestine, Prostate, Breast, and other Organs, Controls multiple Vitamin D-responsive Genes, and THUS plays an important physiologic ROLE in Cardiovascular health,21,22the Adaptive and Innate Immune Responses,23,24insulin secretion,25,26regulation of Cell Proliferation, Differentiation, and Apoptosis, and inhibition of Angiogenesis.27\n\nVitamin D Homeostasis and functions during Pregnancy\nthe classical function of Vitamin D is to maintain calcium Homeostasis.']	[('IMPORTANT_CONSIDERATION', 419), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 478), ('PROBABLE_UNDERSTANDING', 900), ('SUPERFICIAL_RELATIONSHIP', 936)]	5	[('UBERON_0002113', 'kidney', 42, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 105, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 117, '1,25-dihydroxyvitamin D'), ('CHEBI_35885', 'secondary phosphine', 219, 'phosphorus'), ('UBERON_0001555', 'digestive tract', 250, 'gut'), ('GO_0055073', 'cadmium ion homeostasis', 275, 'calcium homeostasis'), ('UBERON_0008883', 'osteoid', 325, 'osteoid'), ('UBERON_0002113', 'kidney', 353, 'renal'), ('CHEBI_4056', 'cytochrome', 380, 'cytochrome'), ('PR_000006100', 'aromatase', 380, 'cytochrome P450'), ('PR_000006138', 'cytochrome P450 4F11', 397, 'CYP ... 27B1'), ('GO_0009057', 'macromolecule catabolic process', 440, 'synthesis'), ('CHEBI_67472', '15-epi-lupulin B', 453, '1,25-dihydroxyvitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 495, 'CYP27B1'), ('GO_0010467', 'gene expression', 506, 'expressed'), ('UBERON_0002481', 'bone tissue', 519, 'nonrenal tissues'), ('CHEBI_67469', '15-hydroxyajubractin C', 547, '1,25 dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 588, 'vitamin D'), ('GO_0010467', 'gene expression', 617, 'expressed'), ('UBERON_0000062', 'organ', 643, 'organs'), ('UBERON_0000479', 'tissue', 651, 'tissues'), ('CHEBI_67472', '15-epi-lupulin B', 690, '1,25-dihydroxyvitamin D'), ('UBERON_0005292', 'extraembryonic tissue', 734, 'extrarenal tissues'), ('CL_0000169', 'type B pancreatic cell', 776, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 776, 'pancreatic'), ('UBERON_0000160', 'intestine', 803, 'intestine'), ('UBERON_0002367', 'prostate gland', 814, 'prostate'), ('UBERON_0000310', 'breast', 824, 'breast'), ('UBERON_0000062', 'organ', 842, 'organs'), ('GO_0065007', 'biological regulation', 850, 'controls'), ('CHEBI_27300', 'vitamin D', 868, 'vitamin D'), ('SO_0000704', 'gene', 889, 'genes'), ('UBERON_0004535', 'cardiovascular system', 944, 'cardiovascular'), ('GO_0051886', 'negative regulation of timing of anagen', 975, 'adaptive ...'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 988, 'innate immune responses'), ('UBERON_0002405', 'immune system', 995, 'immune'), ('GO_0030154', 'cell differentiation', 1054, 'cell proliferation ... differentiation'), ('GO_0006915', 'apoptotic process', 1095, 'apoptosis'), ('GO_0001525', 'angiogenesis', 1124, 'angiogenesis'), ('CHEBI_28384', 'vitamin K', 1141, 'Vitamin D'), ('GO_0042592', 'homeostatic process', 1151, 'homeostasis'), ('GO_0007565', 'female pregnancy', 1184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1220, 'vitamin D'), ('GO_0042592', 'homeostatic process', 1253, 'homeostasis')]
S15-PMC3702339	PMC3702339	6/2013	S15-PMC3702339	['the world health organization (who) defines Vitamin A deficiency (vad) AS Tissue concentrations of Vitamin A (Va) low enough to have adverse health consequences, EVEN IF there is no evidence of clinical deficiency (3).']	[('PROBABLE_UNDERSTANDING', 71), ('ANOMALY_CURIOUS_FINDING', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('UBERON_0000479', 'tissue', 74, 'tissue'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin A'), ('CHEBI_37958', 'dye', 110, 'VA')]
S91-PMC3713405	PMC3713405	7/2013	S91-PMC3713405	['in the developing Brain, levels of Vitamin D Receptor (Vdr) Expression COINCIDE with increasing levels of Apoptosis and decreasing levels of mitosis (burket et al., 2003) SUGGESTING similar actions TO that SEEN in peripheral Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('INCOMPLETE_EVIDENCE', 171), ('QUESTION_ANSWERED_BY_THIS_WORK', 198), ('INCOMPLETE_EVIDENCE', 206)]	4	[('UBERON_0000955', 'brain', 18, 'brain'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 35, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 55, 'VDR'), ('GO_0010467', 'gene expression', 60, 'expression'), ('GO_0006915', 'apoptotic process', 106, 'apoptosis'), ('UBERON_0000479', 'tissue', 225, 'tissue')]
S1-PMC3717170	PMC3717170	5/2013	S1-PMC3717170	['the POSSIBILITY of Extraskeletal EFFECTS of Vitamin D was FIRST NOTED with the discovery of the Vitamin D Receptor (vdr) in Tissues and cells that are not involved in maintaining Mineral Homeostasis and bone health, including skin, Placenta, Pancreas, Breast, Prostate and Colon cancer cells, and Activated T Cells.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 58), ('ANOMALY_CURIOUS_FINDING', 64)]	4	[('UBERON_0001431', 'distal carpal bone 2', 19, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 96, 'vitamin D receptor'), ('UBERON_0000479', 'tissue', 124, 'tissues'), ('CHEBI_46662', 'mineral', 179, 'mineral'), ('GO_0055085', 'transmembrane transport', 179, 'mineral homeostasis'), ('UBERON_0001987', 'placenta', 232, 'placenta'), ('UBERON_0001264', 'pancreas', 242, 'pancreas'), ('UBERON_0000310', 'breast', 252, 'breast'), ('UBERON_0002367', 'prostate gland', 260, 'prostate'), ('UBERON_0001155', 'colon', 273, 'colon'), ('CL_0002129', 'regular atrial cardiac myocyte', 297, 'activated T cells')]
S2-PMC3717170	PMC3717170	5/2013	S2-PMC3717170	['HOWEVER, the biological significance of the Expression of the vdr in different Tissues is not FULLY understood, and the ROLE of Vitamin D in Extraskeletal health HAS been a matter of DEBATE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 94), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183)]	5	[('GO_0010467', 'gene expression', 44, 'expression'), ('UBERON_0000479', 'tissue', 79, 'tissues'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 141, 'extraskeletal')]
S6-PMC3717170	PMC3717170	5/2013	S6-PMC3717170	['WHETHER Ingested OR synthesized, Vitamin D is transported to the Liver, where it is hydroxylated at position 25 to form 25-Hydroxyvitamin D (25(Oh)d2or 25(Oh)D3), the major circulating form of Vitamin D. next, 25(Oh)D3Is transported to the Kidney, where it is hydroxylated at position 1 by the enzyme Cyp27B1 to form 1,25-Dihydroxyvitamin D (1,25(Oh)2D3), the most active form of Vitamin D, which is then transported to target Tissues, where it functions like a Steroid, binding to the Vitamin D receptor (vdr).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('GO_0007631', 'feeding behavior', 8, 'ingested'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0002107', 'liver', 65, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 120, '25-hydroxyvitamin D'), ('CHEBI_63056', 'zinc cation', 141, '25(OH'), ('CHEBI_62946', 'ammonium sulfate', 152, '25(OH)D3'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_71667', '2,3,4-saturated fatty acid', 210, '25(OH)D3is'), ('UBERON_0002113', 'kidney', 240, 'kidney'), ('PR_000006101', 'cytochrome P450 1A1', 301, 'CYP27B1'), ('CHEBI_67472', '15-epi-lupulin B', 317, '1,25-dihydroxyvitamin D'), ('CHEBI_72779', '11-trans-LTE4', 342, '1,25(OH)2D3'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('UBERON_0000479', 'tissue', 427, 'tissues'), ('CHEBI_35341', 'steroid', 462, 'steroid'), ('CHEBI_27300', 'vitamin D', 486, 'vitamin D')]
S10-PMC3717170	PMC3717170	5/2013	S10-PMC3717170	['WHILE it was LONG HELD that Vitamin D ACTED only at the Intestine, Kidney, and Skeleton, and that its function was LIMITED to calcium Homeostasis, the POSSIBILITY of Extraskeletal EFFECTS HAS BEEN CONSIDERED for decades AS a result of the discovery of the vdr in Tissues that have no involvement in Calcium Homeostasis (e.g., skin, Placenta, Pancreas, Breast, Prostate and Colon cancer cells, and Activated T Cells).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 151), ('SUPERFICIAL_RELATIONSHIP', 180), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('PROBABLE_UNDERSTANDING', 220)]	10	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0000160', 'intestine', 56, 'intestine'), ('UBERON_0002113', 'kidney', 67, 'kidney'), ('UBERON_0004288', 'skeleton', 79, 'skeleton'), ('GO_0042592', 'homeostatic process', 134, 'homeostasis'), ('UBERON_0001431', 'distal carpal bone 2', 166, 'extraskeletal'), ('UBERON_0000479', 'tissue', 263, 'tissues'), ('GO_0055073', 'cadmium ion homeostasis', 299, 'calcium homeostasis'), ('UBERON_0001987', 'placenta', 332, 'placenta'), ('UBERON_0001264', 'pancreas', 342, 'pancreas'), ('UBERON_0000310', 'breast', 352, 'breast'), ('UBERON_0002367', 'prostate gland', 360, 'prostate'), ('UBERON_0001155', 'colon', 373, 'colon'), ('CL_0002129', 'regular atrial cardiac myocyte', 397, 'activated T cells')]
S11-PMC3717170	PMC3717170	5/2013	S11-PMC3717170	['discovery of the vdr and Cyp27B1 in these Tissues led to exploration of the ROLES and mechanisms of Vitamin D function in each.']	[('SUPERFICIAL_RELATIONSHIP', 76)]	1	[('PR_000006101', 'cytochrome P450 1A1', 25, 'CYP27B1'), ('UBERON_0000479', 'tissue', 42, 'tissues'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
S12-PMC3717170	PMC3717170	5/2013	S12-PMC3717170	['on september 21, 2012, the abbott nutrition health institute and the sackler institute for nutrition science at the new york academy of sciences sponsored a conference, “Vitamin D: beyond bone,” that gathered researchers investigating Vitamin D in a WIDE range of Tissues and diseases.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 250)]	1	[('CHEBI_28384', 'vitamin K', 170, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('UBERON_0000479', 'tissue', 264, 'tissues')]
S40-PMC3717170	PMC3717170	5/2013	S40-PMC3717170	['HOWEVER, it is IMPORTANT TO RECOGNIZE that similar antibacterial responses to Vitamin D HAVE also BEEN REPORTED for OTHER cell types within Tissues, such as the skin, Lungs, Gi Tract, and Placenta, that MAY broadly be termed barrier sites .']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 203)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000479', 'tissue', 140, 'tissues'), ('UBERON_0002048', 'lung', 167, 'lungs'), ('UBERON_0000993', 'oviduct', 174, 'GI tract'), ('UBERON_0001987', 'placenta', 188, 'placenta')]
S175-PMC3717170	PMC3717170	5/2013	S175-PMC3717170	['INTERESTINGLY, vdr Expression in Human muscle Tissue decreases with Aging, and Vitamin D level is STRONGLY CORRELATED with muscle quality and lower muscle fat infiltration.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('GO_0010467', 'gene expression', 19, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 33, 'human'), ('UBERON_0000479', 'tissue', 46, 'tissue'), ('GO_0007568', 'aging', 68, 'aging'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
S174-PMC3760821	PMC3760821	9/2013	S174-PMC3760821	['POTENTIAL mechanisms by which Vitamin D MIGHT INFLUENCE Glycaemic Control in t1dm include, the IMPACT of this Vitamin on Intracellular Calcium Regulation and, THUS, Glucose transport in target Tissues, INFLUENCES on Insulin receptor Expression and the EFFECT of Vitamin D on systemic inflammation ASSOCIATED with Insulin resistance[31],[32].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 95), ('PROBABLE_UNDERSTANDING', 159), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 252), ('SUPERFICIAL_RELATIONSHIP', 297)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0051162', 'L-arabitol metabolic process', 56, 'glycaemic control'), ('CHEBI_33229', 'vitamin (role)', 110, 'vitamin'), ('GO_0005622', 'intracellular anatomical structure', 121, 'intracellular'), ('GO_0006260', 'DNA replication', 121, 'intracellular'), ('GO_0051303', 'establishment of chromosome localization', 135, 'calcium regulation'), ('CHEBI_17234', 'glucose', 165, 'glucose'), ('UBERON_0000479', 'tissue', 193, 'tissues'), ('PR_000045358', 'insulin family protein', 216, 'insulin'), ('GO_0010467', 'gene expression', 233, 'expression'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('PR_000045358', 'insulin family protein', 313, 'insulin')]
S20-PMC3827489	PMC3827489	10/2013	S20-PMC3827489	['IN LIGHT OF the near universal Expression of the vdr across Tissues, Vitamin D would be expected to play a ROLE in diseases OTHER than those of bone.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	3	[('GO_0010467', 'gene expression', 31, 'expression'), ('UBERON_0000479', 'tissue', 60, 'tissues'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
S28-PMC3888066	PMC3888066	12/2012	S28-PMC3888066	['in addition, studying fetal Mice with knock out lesions for Comi and Retinol Binding Protein, kim et al “demonstrate UNEQUIVOCALLY that Beta Carotene CAN serve as an alternative Vitamin A source for the in situ Synthesis Of Retinoids in developing Tissues by the action of cmoi.”4\nthe equation for isomerization with 13-Trans Retinoic Acid as the energy-favored conformation is:isomerase13-cis\u2009Retinoic\u2009Acid↔13-Trans\u2009Retinoic\u2009Acid\nclearly, an increase in the concentration of 13-Trans Retinoic Acid will shift the equilibrium to the left, increasing Production Of Teratogenic 13-Cis Retinoic Acid.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('INCOMPLETE_EVIDENCE', 150)]	2	[('NCBITaxon_10088', 'Mus <genus>', 28, 'mice'), ('PR_000003266', 'collagen type II alpha chain', 60, 'COMI'), ('CHEBI_26536', 'retinoic acid', 69, 'retinol'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 69, 'retinol binding protein'), ('CHEBI_51438', 'D-isoascorbic acid', 136, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('GO_0010198', 'synergid death', 211, 'synthesis of retinoids'), ('CHEBI_26537', 'retinoid', 224, 'retinoids'), ('UBERON_0000479', 'tissue', 248, 'tissues'), ('CHEBI_38356', 'trans-hex-4-enoic acid', 317, '13-trans retinoic acid'), ('CHEBI_26536', 'retinoic acid', 394, 'retinoic acid'), ('CHEBI_38356', 'trans-hex-4-enoic acid', 408, '13-trans retinoic acid'), ('CHEBI_37983', 'sulfur-35 atom', 476, '13-'), ('CHEBI_64330', 'wybutoxosine', 479, 'trans retinoic acid'), ('GO_0007565', 'female pregnancy', 550, 'production of'), ('CHEBI_50905', 'teratogenic agent', 564, 'teratogenic'), ('GO_0006572', 'tyrosine catabolic process', 564, 'teratogenic ... retinoic acid'), ('CHEBI_61206', '2-hexenoic acid', 576, '13-cis retinoic acid')]
S126-PMC3926113	PMC3926113	1/2014	S126-PMC3926113	['SOME in-vivo STUDIES HAVE SHOWN that Intake of high vitc results in an increased Vitamin E in Tissues[5,17,18].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21)]	2	[('GO_0007631', 'feeding behavior', 37, 'intake'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin E'), ('UBERON_0000479', 'tissue', 94, 'tissues')]
S19-PMC3991049	PMC3991049	11/2013	S19-PMC3991049	['Vitamin D receptors can be found in most Tissues and cells in the body, and the IMPACT of a Vitamin D deficiency on the developing fetus and maternal health is of significant CONCERN.']	[('SUPERFICIAL_RELATIONSHIP', 80), ('PROBLEM_COMPLICATION', 175)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000479', 'tissue', 41, 'tissues'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
S68-PMC3991049	PMC3991049	11/2013	S68-PMC3991049	['SEVERAL STUDIES have REPORTED ASSOCIATION between infant size and Vitamin D status.13,14reduced concentration of 25-Hydroxyvitamin D in mothers during late Pregnancy is ASSOCIATED with reduced Whole Body and Lumbar-Spine bone Mineral content in their children at the age of 9 years.15several studies HYPOTHESIZED that low Prenatal and Perinatal Vitamin D concentrations AFFECT the functional characteristics of various Tissues of the body, which leads to greater risk in later Life of multiple sclerosis, cancer, Insulin-dependent diabetes mellitus and schizophrenia.16,17\nthe current RECOMMENDED dose of Vitamin D during Pregnancy DIFFERS in DIFFERENT parts of the world.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 300), ('SUPERFICIAL_RELATIONSHIP', 370), ('FUTURE_WORK', 585), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 632), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643)]	9	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 113, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy'), ('UBERON_0000468', 'multicellular organism', 193, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 208, 'lumbar-spine'), ('CHEBI_46662', 'mineral', 226, 'mineral'), ('GO_0007565', 'female pregnancy', 322, 'prenatal'), ('GO_0036268', 'swimming', 335, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 335, 'perinatal'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0000479', 'tissue', 419, 'tissues'), ('UBERON_0000104', 'life cycle', 477, 'life'), ('PR_000045358', 'insulin family protein', 513, 'insulin'), ('CHEBI_27300', 'vitamin D', 605, 'vitamin D'), ('GO_0007565', 'female pregnancy', 622, 'pregnancy')]
S71-PMC3991049	PMC3991049	11/2013	S71-PMC3991049	['we used a 50,000 iu dose, AS per our PREVIOUS STUDIES, which DEMONSTRATED no toxicity when Vitamin D deficient rheumatology outpatient and health care professional were supplemented this dose.31–32\nthe CONCERN of using higher doses of Vitamin D MIGHT cause hypercalcemia, hypercalciuria, Renal calculi and soft Tissue and vascular calcification toxicity is LIKELY to worsen with Calcium supplementation.']	[('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 202), ('PROBLEM_COMPLICATION', 202), ('INCOMPLETE_EVIDENCE', 245), ('PROBABLE_UNDERSTANDING', 357)]	7	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('UBERON_0002113', 'kidney', 288, 'renal'), ('UBERON_0000479', 'tissue', 311, 'tissue'), ('CHEBI_22313', 'alkaline earth metal atom', 379, 'calcium')]
S484-PMC4113768	PMC4113768	7/2014	S484-PMC4113768	['background: Vitamin D MAY INFLUENCE Tissue Modelling and Repair in the Lungs throughout Life and THUS low levels of Vitamin D MAY have a negative IMPACT on Lung function.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 26), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 146)]	5	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('GO_0048771', 'tissue remodeling', 36, 'tissue modelling'), ('UBERON_0000479', 'tissue', 36, 'tissue'), ('GO_0006281', 'DNA repair', 57, 'repair'), ('UBERON_0002048', 'lung', 71, 'lungs'), ('UBERON_0000104', 'life cycle', 88, 'life'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0002048', 'lung', 156, 'lung')]
S851-PMC4113768	PMC4113768	7/2014	S851-PMC4113768	['clinical and laboratory evidence SUGGEST that muscle is a target Tissue for Vitamin D, with myopathy a RECOGNISED feature of d deficient Individuals and receptors present in Skeletal muscle.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 103)]	2	[('UBERON_0000479', 'tissue', 65, 'tissue'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('NCBITaxon_1', 'root', 137, 'individuals'), ('UBERON_0004288', 'skeleton', 174, 'skeletal')]
S852-PMC4113768	PMC4113768	7/2014	S852-PMC4113768	['most data regarding the EFFECTS of Vitamin D on non-Skeletal Tissues in young People HAS BEEN obtained from cross-sectional studies, with their ASSOCIATED LIMITATIONS.we have THEREFORE UNDERTAKEN a systematic review of randomised controlled trials (rcts) that has EXAMINED the IMPACT of Vitamin D on muscle strength and function in young People.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 144), ('INCOMPLETE_EVIDENCE', 155), ('PROBLEM_COMPLICATION', 155), ('PROBABLE_UNDERSTANDING', 175), ('QUESTION_ANSWERED_BY_THIS_WORK', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 264), ('SUPERFICIAL_RELATIONSHIP', 277)]	9	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0004288', 'skeleton', 52, 'skeletal'), ('UBERON_0000479', 'tissue', 61, 'tissues'), ('NCBITaxon_10088', 'Mus <genus>', 78, 'people'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 338, 'people')]
S2781-PMC4113768	PMC4113768	7/2014	S2781-PMC4113768	['EVIDENCE from other Tissues INDICATES that local Synthesis Of active Vitamin D (1,25-Dihydroxy Vitamin D; 1,25(Oh)2D3) INFLUENCES Immune Responses and in particular Tlr Signalling.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 119)]	3	[('UBERON_0000479', 'tissue', 20, 'tissues'), ('GO_0051610', 'serotonin uptake', 49, 'synthesis of ... vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 80, '1,25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_73281', '(2S)-versicolorone(1-)', 107, ',25(OH)2D3'), ('GO_0006955', 'immune response', 130, 'immune responses'), ('UBERON_0002405', 'immune system', 130, 'immune'), ('GO_0031929', 'TOR signaling', 165, 'TLR signalling')]
S192-PMC4221707	PMC4221707	11/2014	S192-PMC4221707	['inadequate Intake of either Calcium or Vitamin D CAN LEAD TO disturbances in mineralized Tissues of the foetus [13].']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('GO_0007631', 'feeding behavior', 11, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 28, 'calcium'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0000479', 'tissue', 89, 'tissues')]
S98-PMC4251419	PMC4251419	12/2014	S98-PMC4251419	['a PROPOSED network of INTERACTIONS between Vitamin D and the microbiome that MAY sway the Development Of Immune Tolerance or Tissue Inflammation\nActivation Of Immune Cells like Monocytes and Epithelial cells by bacterial-derived products (e.g.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 22), ('INCOMPLETE_EVIDENCE', 77)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0032253', 'dense core granule localization', 90, 'development of ... tolerance ... inflammation'), ('UBERON_0002405', 'immune system', 105, 'immune'), ('UBERON_0000479', 'tissue', 125, 'tissue'), ('GO_0006915', 'apoptotic process', 145, 'Activation of immune cells'), ('CL_0000738', 'leukocyte', 159, 'immune cells'), ('UBERON_0002405', 'immune system', 159, 'immune'), ('CL_0000576', 'monocyte', 177, 'monocytes'), ('CL_0000066', 'epithelial cell', 191, 'epithelial'), ('UBERON_0000483', 'epithelium', 191, 'epithelial')]
S101-PMC4251419	PMC4251419	12/2014	S101-PMC4251419	['ALTERNATIVELY, microbiome changes, like those induced following the use of Probiotics, MAY Regulate the responsiveness of Immune Cells to Vitamin D by enhancing the Expression of the Vitamin D receptor (vdr) THUS reducing Tissue inflammation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 87), ('PROBABLE_UNDERSTANDING', 208)]	3	[('CHEBI_26346', 'prostaglandins J', 75, 'probiotics'), ('GO_0065007', 'biological regulation', 91, 'regulate'), ('CL_0000738', 'leukocyte', 122, 'immune cells'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('GO_0007567', 'parturition', 129, 'cells'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0010467', 'gene expression', 165, 'expression'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('UBERON_0000479', 'tissue', 222, 'tissue')]
S116-PMC4251419	PMC4251419	12/2014	S116-PMC4251419	['we ANTICIPATE that a deeper understanding of HOW Vitamin D Modulates the microbiomes of the skin and other Tissues will come through ONGOING Vitamin D supplementation trials [74].']	[('IMPORTANT_CONSIDERATION', 3), ('IMPORTANT_CONSIDERATION', 3), ('EXPLICIT_QUESTION', 45), ('IMPORTANT_CONSIDERATION', 133)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0065007', 'biological regulation', 59, 'modulates'), ('UBERON_0000479', 'tissue', 107, 'tissues'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
S117-PMC4251419	PMC4251419	12/2014	S117-PMC4251419	['other studies SUGGEST that the microbiome MAY modify the capacity of Tissue Regulation by Vitamin D. in Rodent MODELS, Probiotics CAN upregulate Expression of the vdr in the Colon, reducing inflammation and delaying the transition to dysplasia and cancer [75].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 130)]	5	[('UBERON_0000479', 'tissue', 69, 'tissue'), ('GO_0065007', 'biological regulation', 76, 'regulation'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 104, 'rodent'), ('CHEBI_26346', 'prostaglandins J', 119, 'probiotics'), ('GO_0010467', 'gene expression', 145, 'expression'), ('UBERON_0001155', 'colon', 174, 'colon')]
S120-PMC4251419	PMC4251419	12/2014	S120-PMC4251419	['these data SUGGEST that NOT ONLY can Vitamin D Modulate Tissue inflammation through modifications to the microbiome, BUT the reverse is also POSSIBLE—the microbiome and inflammation can change the responsiveness of Tissues to Vitamin D through Regulation of the vdr.']	[('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 24), ('INCOMPLETE_EVIDENCE', 141)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0065007', 'biological regulation', 47, 'modulate'), ('UBERON_0000479', 'tissue', 56, 'tissue'), ('UBERON_0000479', 'tissue', 215, 'tissues'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0065007', 'biological regulation', 244, 'regulation')]
S185-PMC4277121	PMC4277121	12/2015	S185-PMC4277121	['antioxidants\noxidative stress and Mitochondrial dysfunction are both CONSIDERED hallmarks of ds Tissues and CONTRIBUTORS to Neurological phenotypes across the ds Lifespan.1,91cortical Neurons derived from ds fetal Brains show elevated levels of Reactive Oxygen Species, and survival is enhanced by treatment with Antioxidants.92several Hsa21 Genes, among them Sod1 , Bach1 , ets2 , and S100B , are KNOWN to CONTRIBUTE to the Regulation of oxidative stress when Overexpressed.9CONSISTENT with these OBSERVATIONS, it was SHOWN that levels of oxidative stress are elevated in the Brains of Adult ts65dn, and when male ts65dn Mice were Fed a diet high in Vitamin E (0.4 g per kg) from the age of 4 months to ~8 months and 10 months, the levels of oxidative stress were decreased.93performance in the Wram was improved at 8 months, and at 10 months; loss of the Trka receptor in the Bfcn had been PREVENTED.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 398), ('SUPERFICIAL_RELATIONSHIP', 407), ('SUPERFICIAL_RELATIONSHIP', 425), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 519), ('SUPERFICIAL_RELATIONSHIP', 892)]	11	[('GO_0005739', 'mitochondrion', 34, 'mitochondrial'), ('UBERON_0000479', 'tissue', 96, 'tissues'), ('UBERON_0001016', 'nervous system', 124, 'neurological'), ('UBERON_0000104', 'life cycle', 162, 'lifespan'), ('CL_0000540', 'neuron', 184, 'neurons'), ('UBERON_0000955', 'brain', 214, 'brains'), ('CHEBI_26523', 'reactive oxygen species', 245, 'reactive oxygen species'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 313, 'antioxidants'), ('PR_000008820', 'heat shock protein beta-8', 336, 'Hsa21'), ('SO_0000704', 'gene', 342, 'genes'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 360, 'SOD1'), ('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 367, 'BACH1'), ('PR_000014404', 'protein S100-A11', 386, 'S100B'), ('GO_0065007', 'biological regulation', 425, 'regulation'), ('GO_0003054', 'circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus', 461, 'overexpressed'), ('UBERON_0000955', 'brain', 577, 'brains'), ('UBERON_0007023', 'adult organism', 587, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 622, 'mice'), ('GO_0007631', 'feeding behavior', 632, 'fed'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin E'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 796, 'WRAM'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 857, 'TRKA'), ('UBERON_0001943', 'midbrain tegmentum', 878, 'BFCN')]
S160-PMC4302429	PMC4302429	1/2015	S160-PMC4302429	['moreover, Vitamin D has anti-inflammatory properties, illustrated in THIS STUDY by increased anti-inflammatory Il-10 and decreased proinflammatory Il-6 concentrations in Brain Tissue.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 69)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 111, 'IL-10'), ('PR_000001470', 'interleukin-28B', 147, 'IL-6'), ('UBERON_0000955', 'brain', 170, 'brain'), ('UBERON_0000479', 'tissue', 176, 'tissue')]
S103-PMC4377870	PMC4377870	3/2015	S103-PMC4377870	['the CONFLICTING results from these supplementation studies are LIKELY to be INFLUENCED by baseline Tissue levels of Vitamin E [72], with Α-Tocopherol supplementation leading to improved Lung function and wheeze in europe, where Γ-Tocopherol levels are low [78,79,80], BUT NOT in the us, where γ-Tocopherol Intake is high due to Soybean oil Consumption [81,82,83].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 76), ('FULL_UNKNOWN', 268), ('ANOMALY_CURIOUS_FINDING', 272)]	5	[('UBERON_0000479', 'tissue', 99, 'tissue'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin E'), ('CHEBI_27725', 'butin', 137, 'α-tocopherol'), ('UBERON_0002048', 'lung', 186, 'lung'), ('CHEBI_27725', 'butin', 228, 'γ-tocopherol'), ('CHEBI_27013', 'tocopherol', 295, 'tocopherol'), ('GO_0007631', 'feeding behavior', 306, 'intake'), ('CHEBI_36933', 'oxygen-19 atom', 328, 'soybean'), ('GO_0007631', 'feeding behavior', 340, 'consumption')]
S94-PMC4427001	PMC4427001	4/2015	S94-PMC4427001	['in addition, Vitamin D MAY also be NEEDED to ensure a normal rate of Calcium Flux Across Cell Membranes and maintenance of an adequate Cytosolic calcium pool, which is IMPORTANT for Insulin-mediated Intracellular Signalling in Insulin-responsive Tissues [35].']	[('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 35), ('IMPORTANT_CONSIDERATION', 168)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_1990171', 'SCF complex disassembly in response to cadmium stress', 69, 'calcium flux across cell membranes'), ('GO_0005886', 'plasma membrane', 89, 'cell membranes'), ('GO_0005829', 'cytosol', 135, 'cytosolic'), ('PR_000045358', 'insulin family protein', 182, 'insulin'), ('GO_0005622', 'intracellular anatomical structure', 199, 'intracellular'), ('GO_0035556', 'intracellular signal transduction', 199, 'intracellular signalling'), ('PR_000045358', 'insulin family protein', 227, 'insulin'), ('UBERON_0000479', 'tissue', 246, 'tissues')]
S471-PMC4448820	PMC4448820	5/2015	S471-PMC4448820	['ALTHOUGH Vitamin A is absolutely REQUIRED for mounting an effective Immune Response, it is TEMPTING to SPECULATE that temporarily inhibiting Plasma Delivery Of Vitamin A to Tissues is beneficial to the host by creating a favorable environment for inflammation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 103)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin A'), ('GO_0006955', 'immune response', 68, 'immune response'), ('UBERON_0002405', 'immune system', 68, 'immune'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('GO_0070983', 'dendrite guidance', 148, 'delivery of vitamin A'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin A'), ('UBERON_0000479', 'tissue', 173, 'tissues')]
S39-PMC4488777	PMC4488777	5/2015	S39-PMC4488777	['the EFFECT of Vitamin D on Ovarian Granulosa Cells RESPONSIBLE for Steroidogenesis, as well as on Immune System Regulation, was ESTABLISHED after FINDING 1-α-hydroxylase and vdr receptors in Deciduae, Placentas, Ovaries, Endometriums and Pituitary Glands, and was CONFIRMED in vitro by DEMONSTRATING active Metabolites of Vitamin D such as 1,25[Oh]2D and 24,25[Oh]2D in mentioned Tissues [14,15,16,17,18].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CL_0000477', 'ovarian follicle cell', 27, 'ovarian granulosa cells'), ('UBERON_0000992', 'ovary', 27, 'ovarian'), ('GO_0001501', 'skeletal system development', 67, 'steroidogenesis'), ('UBERON_0002405', 'immune system', 98, 'immune system'), ('GO_0065007', 'biological regulation', 112, 'regulation'), ('UBERON_0002450', 'decidua', 191, 'deciduae'), ('UBERON_0001987', 'placenta', 201, 'placentas'), ('UBERON_0000992', 'ovary', 212, 'ovaries'), ('UBERON_0001852', 'endolymph', 221, 'endometriums'), ('UBERON_0000007', 'pituitary gland', 238, 'pituitary glands'), ('CHEBI_25212', 'metabolite', 307, 'metabolites'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 342, '25[OH]2D'), ('CHEBI_82784', 'PVP38-Ag NP', 358, '25[OH]2D'), ('UBERON_0000479', 'tissue', 380, 'tissues')]
S69-PMC4514967	PMC4514967	12/2014	S69-PMC4514967	['ra is generated from dietary Vitamin A through a number of steps, the final being conversion of Retinal to ra by Retinal dehydrogenase.53ALTHOUGH various cell types can perform this transformation, apcs, specifically those at Tissue sites like the Intestine and skin, are specialized in the provision of ra for Modulation Of Immune Responses.']	[('ANOMALY_CURIOUS_FINDING', 135)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin A'), ('UBERON_0000966', 'retina', 96, 'retinal'), ('UBERON_0000966', 'retina', 113, 'retinal'), ('UBERON_0000479', 'tissue', 226, 'tissue'), ('UBERON_0000160', 'intestine', 248, 'intestine'), ('GO_0006880', 'intracellular sequestering of iron ion', 311, 'modulation of immune responses'), ('UBERON_0002405', 'immune system', 325, 'immune')]
S116-PMC4690051	PMC4690051	12/2015	S116-PMC4690051	['the presence of 1α-hydroxylase activity within numerous Brain Regions SUGGESTS that Brain Tissue can locally produce Metabolically active Vitamin D, further IMPLICATING a ROLE for Vitamin D in Brain Development.']	[('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 157), ('SUPERFICIAL_RELATIONSHIP', 171)]	3	[('UBERON_0002616', 'regional part of brain', 56, 'brain regions'), ('UBERON_0000955', 'brain', 84, 'brain'), ('UBERON_0000479', 'tissue', 90, 'tissue'), ('GO_0008152', 'metabolic process', 117, 'metabolically'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0007420', 'brain development', 193, 'brain development'), ('UBERON_0000955', 'brain', 193, 'brain')]
S19-PMC4729160	PMC4729160	1/2016	S19-PMC4729160	['the world health organization (who) DEFINES vitamin a deficiency (vad) AS Tissue concentrations of Vitamin A (Va) low enough to have adverse health consequences, EVEN IF there is no evidence of clinical deficiency [2].']	[('PROBABLE_UNDERSTANDING', 36), ('PROBABLE_UNDERSTANDING', 71), ('ANOMALY_CURIOUS_FINDING', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	4	[('UBERON_0000479', 'tissue', 74, 'tissue'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin A'), ('CHEBI_37958', 'dye', 110, 'VA')]
S55-PMC4764019	PMC4764019	1/2016	S55-PMC4764019	['THUS, the EFFECTS of Vitamin D inadequacy are as far-RANGING as the Tissues concerned, all of which require Vitamin D to gain access to information stored in their Genes.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000479', 'tissue', 68, 'tissues'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('SO_0000704', 'gene', 164, 'genes')]
S104-PMC4859539	PMC4859539	5/2016	S104-PMC4859539	['additionally, the LACK OF CORRELATION MAY SUGGEST that circulating Cathelicidin concentration is NOT REFLECTIVE of WHAT is happening at the cellular level, and in this regard, cathelicidin mrna Expression by Immune Cells or target Tissue MAY BE a BETTER indicator of Vitamin D’s long-term EFFECT on the Cathelicidin system.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 42), ('FULL_UNKNOWN', 97), ('EXPLICIT_QUESTION', 115), ('INCOMPLETE_EVIDENCE', 238), ('FUTURE_PREDICTION', 247), ('SUPERFICIAL_RELATIONSHIP', 289)]	9	[('CHEBI_3364', 'Canthiumine', 67, 'cathelicidin'), ('GO_0010467', 'gene expression', 194, 'expression'), ('CL_0000738', 'leukocyte', 208, 'immune cells'), ('UBERON_0002405', 'immune system', 208, 'immune'), ('UBERON_0000479', 'tissue', 231, 'tissue'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 303, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 303, 'cathelicidin')]
S8-PMC4908484	PMC4908484	6/2016	S8-PMC4908484	['ALTHOUGH in Human, most of the Vitamin D that ends up in the Blood is produced in the Kidneys, Vitamin D MAY BE synthesized in OTHER Tissues such as Endothelium, Placenta, Prostate, skin, Colon, Breast, and the Central Nervous System (Cns).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	3	[('NCBITaxon_9606', 'Homo sapiens', 12, 'human'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0000178', 'blood', 61, 'blood'), ('UBERON_0002113', 'kidney', 86, 'kidneys'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0000479', 'tissue', 133, 'tissues'), ('UBERON_0001986', 'endothelium', 149, 'endothelium'), ('UBERON_0001987', 'placenta', 162, 'placenta'), ('UBERON_0002367', 'prostate gland', 172, 'prostate'), ('UBERON_0001155', 'colon', 188, 'colon'), ('UBERON_0000310', 'breast', 195, 'breast'), ('UBERON_0001017', 'central nervous system', 211, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 235, 'CNS')]
S9-PMC4908484	PMC4908484	6/2016	S9-PMC4908484	['the Production Of Vitamin D by these Tissues/Organs is low compared to the amount produced by Kidneys, and this Vitamin D is PROBABLY not released back into the Blood BUT acts within the Tissue where it is made (garcion et\xa0al.2002; tetich et\xa0al.2004; cranney et\xa0al.2007).']	[('PROBABLE_UNDERSTANDING', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	2	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 4, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000479', 'tissue', 37, 'tissues'), ('UBERON_0000062', 'organ', 45, 'organs'), ('UBERON_0002113', 'kidney', 94, 'kidneys'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0000178', 'blood', 161, 'blood'), ('UBERON_0000479', 'tissue', 187, 'tissue')]
S157-PMC4933662	PMC4933662	4/2016	S157-PMC4933662	['lower Transcript Expression of\xa0Vitamin D Receptor and Interferon Gamma in Skeletal muscle Tissue was ASSOCIATED with higher lean mass and lower Gene Expression of Interleukin 6 (il‐6), Tumour Necrosis Factor‐alpha (Tnf‐Α) and Interleukin‐1 Receptor (Il1R1) in community‐dwelling older men (patel et\xa0al .,2014).']	[('SUPERFICIAL_RELATIONSHIP', 101)]	1	[('SO_0000673', 'transcript', 6, 'transcript'), ('GO_0010467', 'gene expression', 17, 'expression'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 31, 'vitamin D receptor'), ('PR_000002050', 'interferon regulatory factor 8', 54, 'interferon gamma'), ('CHEBI_37958', 'dye', 65, 'gamma'), ('UBERON_0004288', 'skeleton', 74, 'skeletal'), ('UBERON_0000479', 'tissue', 90, 'tissue'), ('GO_0010467', 'gene expression', 144, 'gene expression'), ('SO_0000704', 'gene', 144, 'gene'), ('PR_000008988', 'interleukin-1 family member 5', 163, 'interleukin 6'), ('PR_000016589', 'tumor protein p63-regulated gene 1 protein', 185, 'tumour necrosis factor'), ('PR_000000134', 'tumor necrosis factor alpha', 215, 'TNF‐α'), ('PR_000001364', 'interleukin-1 receptor type II', 226, 'interleukin‐1 receptor'), ('PR_000001385', 'interleukin-27 subunit alpha', 250, 'IL1R1')]
S29-PMC4934634	PMC4934634	11/2015	S29-PMC4934634	['high levels of body fat can Sequester Vitamin D into Adipose Cells THUS reducing its bioavailability to other Tissues.']	[('PROBABLE_UNDERSTANDING', 67)]	1	[('GO_0051235', 'maintenance of location', 28, 'sequester'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CL_0000136', 'fat cell', 53, 'adipose cells'), ('UBERON_2000251', 'adipose fin', 53, 'adipose'), ('UBERON_0000479', 'tissue', 110, 'tissues')]
S40-PMC4934634	PMC4934634	11/2015	S40-PMC4934634	['ILLUSTRATIVE of this, Vitamin D Nuclear receptors (vdr) HAVE BEEN IDENTIFIED in numerous Tissues including Organs INVOLVED in Reproduction and infant growth such as the Ovary, Testis, Placenta and Mammary Gland [14,15].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 114)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0005634', 'nucleus', 32, 'nuclear'), ('UBERON_0000479', 'tissue', 89, 'tissues'), ('UBERON_0000062', 'organ', 107, 'organs'), ('GO_0000003', 'reproduction', 126, 'reproduction'), ('UBERON_0000992', 'ovary', 169, 'ovary'), ('UBERON_0000473', 'testis', 176, 'testis'), ('UBERON_0001987', 'placenta', 184, 'placenta'), ('UBERON_0001911', 'mammary gland', 197, 'mammary gland')]
S80-PMC4971719	PMC4971719	8/2016	S80-PMC4971719	['ALTHOUGH 1, 25-Dihydroxyvitamin D (not 25-Oh-D) is the biologically active form of Vitamin D, circulating levels of 1, 25-dihydroxyvitamin d are not a good representation of Tissue levels, and Tissue levels are not easily measured.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0)]	2	[('CHEBI_67469', '15-hydroxyajubractin C', 9, '1, 25-Dihydroxyvitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 39, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0000479', 'tissue', 174, 'tissue'), ('UBERON_0000479', 'tissue', 193, 'tissue')]
S10-PMC4976416	PMC4976416	7/2016	S10-PMC4976416	['[3]\nthere are eight types of Vitamin E (α-,β-,Γ-, and Σ-Tocopherols and their RELATED corresponding Tocotrienols), Γ-Tocopherol being the most abundant Tocopherol in diet, WHEREAS Α-Tocopherol (α-Toc) is the most abundant Vitamin E Derivative in Human Tissues and Sera.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin E'), ('CHEBI_66498', 'Ys-IV', 46, 'γ-,'), ('CHEBI_52029', 'dilC18(3) dye', 54, 'σ-'), ('CHEBI_27013', 'tocopherol', 56, 'tocopherols'), ('CHEBI_33257', 'secondary amide', 100, 'tocotrienols'), ('CHEBI_27725', 'butin', 115, 'γ-tocopherol'), ('CHEBI_27013', 'tocopherol', 152, 'tocopherol'), ('CHEBI_27725', 'butin', 180, 'α-tocopherol'), ('CHEBI_27021', 'toluate', 196, 'Toc'), ('CHEBI_84790', 'trans-3-hexenoyl-CoA(4-)', 222, 'vitamin E derivative'), ('NCBITaxon_9606', 'Homo sapiens', 246, 'human'), ('UBERON_0000479', 'tissue', 252, 'tissues'), ('UBERON_0001977', 'blood serum', 264, 'sera')]
S1-PMC4997421	PMC4997421	8/2016	S1-PMC4997421	['BECAUSE maternal Tissue is progressively depleted of Vitamin A to supply fetal demands, women who become Pregnant while possessing marginal Vitamin A reserves are at INCREASED RISK of vitamin a inadequacy as Pregnancy progresses.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 166)]	2	[('UBERON_0000479', 'tissue', 17, 'tissue'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin A'), ('GO_0007565', 'female pregnancy', 105, 'pregnant'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin A'), ('GO_0007565', 'female pregnancy', 208, 'pregnancy')]
S91-PMC4997421	PMC4997421	8/2016	S91-PMC4997421	['BECAUSE maternal Tissues are progressively depleted of Vitamin A to supply fetal demands [14], women who initially possess marginal or EVEN adequate Vitamin A stores at the beginning of Pregnancy are at an INCREASED RISK of Vitamin A inadequacy as Pregnancy progresses.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 135), ('IMPORTANT_CONSIDERATION', 206)]	3	[('UBERON_0000479', 'tissue', 17, 'tissues'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin A'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin A'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy')]
S87-PMC5322422	PMC5322422	2/2017	S87-PMC5322422	['WHILE the differential diagnosis included spontaneous hemorrhage into normal Thymic Tissue, malignancy or Vitamin K ASSOCIATED bleeding into benign or malignant Tissue could not be ruled out.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 116)]	2	[('UBERON_0002370', 'thymus', 77, 'thymic tissue'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin K'), ('UBERON_0000479', 'tissue', 161, 'tissue')]
S13-PMC5340372	PMC5340372	3/2017	S13-PMC5340372	['since the discovery that MOST Tissues and cells have Vitamin D receptors, there has been great INTEREST in its ROLE in the development of many diseases, such as cancer [1], Cardiovascular diseases [2], infectious diseases [3], and Autoimmune disease [4].']	[('PROBABLE_UNDERSTANDING', 25), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('UBERON_0000479', 'tissue', 30, 'tissues'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 173, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 231, 'autoimmune')]
S12-PMC5372327	PMC5372327	3/2017	S12-PMC5372327	['Paracrine Conversion Of 25-Ohd to Calcitriol occurs in many Tissues, such as Dendritic and Endothelial Cells, Brain, Placenta and Parathyroids, underscoring the IMPORTANCE of Vitamin D for these Organs [2].']	[('IMPORTANT_CONSIDERATION', 161)]	1	[('GO_0036518', 'chemorepulsion of dopaminergic neuron axon', 0, 'Paracrine conversion of 25-OHD'), ('CHEBI_72765', 'verruculogen', 24, '25-OHD'), ('CHEBI_17823', 'calcitriol', 34, 'calcitriol'), ('UBERON_0000479', 'tissue', 60, 'tissues'), ('CL_0000451', 'dendritic cell', 77, 'dendritic ...'), ('GO_0030425', 'dendrite', 77, 'dendritic'), ('CL_0000115', 'endothelial cell', 91, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 91, 'endothelial'), ('UBERON_0000955', 'brain', 110, 'brain'), ('UBERON_0001987', 'placenta', 117, 'placenta'), ('UBERON_0001132', 'parathyroid gland', 130, 'parathyroids'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0000062', 'organ', 195, 'organs')]
S13-PMC5372327	PMC5372327	3/2017	S13-PMC5372327	['based ON the number of cell types Expressing Vitamin D receptors (vdr), 38 POTENTIAL target Tissues HAVE BEEN recognised [3].']	[('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 75), ('INCOMPLETE_EVIDENCE', 100)]	3	[('GO_0010467', 'gene expression', 34, 'expressing'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0000479', 'tissue', 92, 'tissues')]
S72-PMC5510234	PMC5510234	7/2017	S72-PMC5510234	['(1994) FOUND a statistically significant CORRELATION between Vitamin A deficiency and mtct rates in 338 hiv-infected women in malawi, SPECULATING that Vitamin A deficiency MAY compromise the Epithelial integrity of Tissues in the Vaginal Mucosa and Mammary Glands.']	[('INCOMPLETE_EVIDENCE', 7), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 134), ('INCOMPLETE_EVIDENCE', 172)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin A'), ('UBERON_0000483', 'epithelium', 191, 'epithelial'), ('UBERON_0000479', 'tissue', 215, 'tissues'), ('UBERON_0004983', 'mucosa of vagina', 230, 'vaginal mucosa'), ('UBERON_0001911', 'mammary gland', 249, 'mammary glands')]
S115-PMC5521778	PMC5521778	7/2017	S115-PMC5521778	['results\n\nBco1 Expression in Human Lung Tissue and Pulmonary Alveolar Epithelial (a549) Cells\nBco1 is prominently Expressed in Human Intestine, Liver, and Kidney [20], CONSISTENT with the key enzymatic function converting pro-Vitamin A Carotenoids to Vitamin A.']	[('INCOMPLETE_EVIDENCE', 167)]	1	[('PR_000004693', 'Bcl-2-like protein 10', 9, 'BCO1'), ('GO_0010467', 'gene expression', 14, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 28, 'human'), ('UBERON_0002048', 'lung', 34, 'lung'), ('UBERON_0000479', 'tissue', 39, 'tissue'), ('CL_0002241', 'pulmonary interstitial fibroblast', 50, 'pulmonary'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 50, 'pulmonary alveolar epithelial'), ('CL_0000322', 'pneumocyte', 60, 'alveolar epithelial ... cells'), ('PR_000004693', 'Bcl-2-like protein 10', 93, 'BCO1'), ('GO_0010467', 'gene expression', 113, 'expressed'), ('NCBITaxon_9606', 'Homo sapiens', 126, 'human'), ('UBERON_0000160', 'intestine', 132, 'intestine'), ('UBERON_0002107', 'liver', 143, 'liver'), ('UBERON_0002113', 'kidney', 154, 'kidney'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin A'), ('CHEBI_50815', 'norgestimate', 235, 'carotenoids'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin A')]
S30-PMC5634602	PMC5634602	10/2017	S30-PMC5634602	['as the ROLE of Vitamin D in Immune function, Respiratory health, allergy and atopic disease, and many other Tissue and Organ functions becomes apparent, adjustments have BEEN SUGGESTED in OPTIMAL Serum level of 25(Oh)D [12–14].']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 170), ('IMPORTANT_CONSIDERATION', 188)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0002405', 'immune system', 28, 'immune'), ('UBERON_0001004', 'respiratory system', 45, 'respiratory'), ('UBERON_0000479', 'tissue', 108, 'tissue'), ('UBERON_0000062', 'organ', 119, 'organ'), ('UBERON_0001977', 'blood serum', 196, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 217, 'D')]
S17-PMC5941617	PMC5941617	5/2018	S17-PMC5941617	['when dietary Calcium intakes are inadequate, Calcitriol INTERACTS with the Vitamin D Receptor (Vdr) Expressed on Osteoblasts, bringing Osteoclasts precursors to maturation and promoting calcium and Phosphorus absorption by Bone Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 56)]	1	[('CHEBI_22313', 'alkaline earth metal atom', 13, 'calcium'), ('CHEBI_17823', 'calcitriol', 45, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 75, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 95, 'VDR'), ('GO_0010467', 'gene expression', 100, 'expressed'), ('CL_0000062', 'osteoblast', 113, 'osteoblasts'), ('CL_0000092', 'osteoclast', 135, 'osteoclasts'), ('CHEBI_35885', 'secondary phosphine', 198, 'phosphorus'), ('GO_0046903', 'secretion', 198, 'phosphorus'), ('UBERON_0001474', 'bone element', 223, 'bone'), ('UBERON_0000479', 'tissue', 228, 'tissue')]
S317-PMC5941617	PMC5941617	5/2018	S317-PMC5941617	['in an usa study a SIMILAR ASSOCIATION was OBSERVED between skin or soft Tissue infections by staphylococcus aureus strains and Vitamin D levels [25(Oh)D\u2009<\u200930\xa0ng/ml] in 202 children [276].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 18), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 42)]	4	[('UBERON_0000479', 'tissue', 72, 'tissue'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 145, '25(OH)D')]
S143-PMC5952272	PMC5952272	5/2018	S143-PMC5952272	['IN fact, it is the most potent Steroid Hormone in the Human body INTERACTING with 2.5% of the Human Genome or some 1000 Genes (a large NUMBER of which AFFECT Brain Development and function) and working like a master on-off switch.35\nthe LINK between Vitamin D and autism are based on 4 observational data:\nthe low concentrations of Serotonin in the Brain and its elevated concentrations in Tissues outside the Blood-Brain Barrier;\nlow Plasma concentrations of the Vitamin D hormone precursor 25-Hydroxyvitamin D (25(Oh) D3);\nhigh male incidence;\npresence of maternal Antibodies to foetal Brain Tissue.35,36\nthe level of Serotonin in the Brain DEPENDS ON the Blood levels of tryptophan, which, UNLIKE Serotonin, crosses the Blood-Brain Barrier.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 151), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 643), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 693)]	7	[('CHEBI_26764', 'steroid hormone', 31, 'steroid hormone'), ('NCBITaxon_9606', 'Homo sapiens', 54, 'human'), ('NCBITaxon_9606', 'Homo sapiens', 94, 'human'), ('SO_0001026', 'genome', 100, 'genome'), ('SO_0000704', 'gene', 120, 'genes'), ('GO_0007420', 'brain development', 158, 'brain development'), ('UBERON_0000955', 'brain', 158, 'brain'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_28790', 'serotonin', 332, 'serotonin'), ('UBERON_0000955', 'brain', 349, 'brain'), ('UBERON_0000479', 'tissue', 390, 'tissues'), ('UBERON_0000120', 'blood brain barrier', 410, 'blood-brain barrier'), ('UBERON_0001969', 'blood plasma', 435, 'plasma'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 492, '25-hydroxyvitamin D'), ('CHEBI_62946', 'ammonium sulfate', 513, '25(OH) D3'), ('GO_0042571', 'immunoglobulin complex, circulating', 567, 'antibodies'), ('UBERON_0000955', 'brain', 588, 'brain'), ('UBERON_0000479', 'tissue', 594, 'tissue'), ('CHEBI_28790', 'serotonin', 620, 'serotonin'), ('UBERON_0000955', 'brain', 637, 'brain'), ('UBERON_0000178', 'blood', 658, 'blood'), ('CHEBI_28790', 'serotonin', 700, 'serotonin'), ('UBERON_0000178', 'blood', 723, 'blood'), ('UBERON_0000052', 'fornix of brain', 729, 'brain barrier')]
